cyclosporine has been researched along with Cardiac Failure in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (24.62) | 18.2507 |
| 2000's | 27 (41.54) | 29.6817 |
| 2010's | 20 (30.77) | 24.3611 |
| 2020's | 2 (3.08) | 2.80 |
| Authors | Studies |
|---|---|
| Fonarow, GC; Hernandez, AF; Yancy, CW | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
| Çetinarslan, Ö; Hüral, R; Ökçün, EÖ | 1 |
| Awan, Z; El-Bassossy, HM; El-Mas, MM | 1 |
| Amaz, C; Claeys, MJ; Coussement, P; Dubois, P; Garcia-Dorado, D; Mewton, N; Ovize, M | 1 |
| Almenar-Bonet, L; Martínez-Dolz, L; Portolés-Sanz, M; Rivera-Otero, M; Rodríguez-Serrano, M; Salvador-Sanz, A; Sánchez-Lázaro, I | 1 |
| Balligand, JL; Bauersachs, J; Clerk, A; De Windt, L; Heymans, S; Hilfiker-Kleiner, D; Hirsch, E; Iaccarino, G; Knöll, R; Leite-Moreira, AF; Lourenço, AP; Mayr, M; Tarone, G; Thum, T; Tocchetti, CG | 1 |
| Andersson, B; Andreassen, AK; Arora, S; Dellgren, G; Eiskjaer, H; Gude, E; Gullestad, L; Gustafsson, F; Jansson, K; Radegran, G; Sigurdardottir, V; Solbu, D | 1 |
| Allain-Rooney, T; Dipchand, AI; He, Y; Manlhiot, C; Pollock-BarZiv, S; Touyz, RM; West, L; White, M | 1 |
| Denfield, SW | 1 |
| Leach, SB; Nafe, LA | 1 |
| Bireta, C; Grossmann, M; Jebran, AF; Perl, T; Popov, AF; Schoendube, FA; Tirilomis, T; Unsöld, B; Wachter, R | 1 |
| Chang, YC; Dong, F; Shi, CX; Wang, XF; Xu, YF | 1 |
| Angoulvant, D; Aupetit, JF; Barragan, P; Béard, T; Belle, L; Bergerot, C; Blanchard, D; Bonnefoy-Cudraz, E; Boussaha, I; Cayla, G; Claeys, MJ; Clerc, J; Colin, P; Coste, P; Cottin, Y; Coussement, P; Cung, TT; De Poli, F; Delarche, N; Derumeaux, G; Dubois, P; Dubois-Randé, JL; Elbaz, M; Elmer, E; Garcia-Dorado, D; Gilard, M; Grollier, G; Guérin, P; Hansson, MJ; Ider, O; Jossan, C; Jouve, B; Labeque, JN; Le Breton, H; Malquarti, V; Metge, M; Mewton, N; Morel, O; Morice, MC; Motreff, P; Moulin, F; Ovize, M; Piot, C; Prunier, F; Range, G; Rioufol, G; Roth, O; Staat, P; Steg, PG; Sudre, A; Tron, C; Unterseeh, T; Vanzetto, G | 1 |
| Nicholls, M | 1 |
| Hirohashi, N; Kida, Y; Kyo, M; Ohshimo, S; Shimatani, T; Shime, N; Suzuki, K; Torikoshi, Y; Yamaga, S | 1 |
| Chen, L; Gong, Q; Knowlton, AA; Stice, JP | 1 |
| Brum, PC; Ferreira, JC; Gomes, ER; Guatimosim, S; Medeiros, A; Oliveira, RS; Paixão, NA; Rolim, NP | 1 |
| Hullin, R; Kalangos, A; Mach, F; Pascual, M; Rotman, S; Vogt, P; von Segesser, L; Yerly, P | 1 |
| Benito, B; Nattel, S | 1 |
| Chen, YS; Chi, NH; Chou, NK; Hsu, KH; Ko, WJ; Lee, PH; Tsai, MK; Tsao, CI; Wang, CH; Wang, SS; Yu, HY | 1 |
| Ekmehag, B; Koul, B; Ljungdahl-Waller, F; Nilsson, J; Senneby, E; Sjögren, J | 1 |
| Arjun, S; Davidson, SM; Hausenloy, DJ; Lim, SY; Lythgoe, MF; Price, AN; Yellon, DM | 1 |
| Dewanji, A; Ghosh, P | 1 |
| Allamargot, C; Anderson, ME; Chen, B; Fink, BD; Gao, Z; Hall, DD; He, BJ; Joiner, ML; Koval, OM; Li, J; Luczak, ED; Mohler, PJ; Moore, SA; Scholz, TD; Sivitz, WI; Song, LS; Strack, S; Yang, J | 1 |
| Ghaffari, S; Kazemi, B; Sepehrvand, N; Toluey, M | 1 |
| Csiszar, A; Edwards, JG; Hainsey, T; Sun, S | 1 |
| Furuse, A; Kawauchi, M; Murota, Y; Takamoto, S; Tanaka, K | 1 |
| Chioléro, R; Corno, A; Fischer, A; Gersbach, P; Goy, JJ; Hurni, M; Mueller, X; Revelly, JP; Ruchat, P; Seydoux, C; Stumpe, F; Tinguely, F; von Segesser, L | 1 |
| Groner, F; Handrock, R; Herzig, S; Jäger, A; Matthes, J; Mehlhorn, U; Schwartz, A; Schwinger, RH; Varadi, G | 1 |
| Massad, MG | 1 |
| Bassano, C; Bevilacqua, M; Boldrini, R; Bottazzo, GF; Camassei, FD; Fierabracci, A; Gagliardi, MG; Leonardi, B; Ugazio, AG | 1 |
| Daebritz, S; Groetzner, J; Kozlik-Feldmann, R; Netz, H; Reichart, B; Reichel, S; Roemer, U; Sachweh, J; Tiete, A | 1 |
| Chen, RJ; Chu, SH; Hsu, RB; Wang, SS | 1 |
| Böhm, M; Ecker, KW; Giese, T; Jüngling, B; Kindermann, I; Moser, C; Püschel, W; Schäfers, HJ; Stallmach, A; Zeuzem, S | 1 |
| Cusimano, RJ; Delgado, DH; Feindel, C; Miriuka, SG; Rao, V; Ross, HJ | 1 |
| Blanz, U; Körfer, R; Meyer, H; Minami, K; Niino, T; Tenderich, G; von Knyphausen, E; Wlost, S | 1 |
| Imai, M; Sabbah, HN; Sharov, VG; Todor, AV | 1 |
| Imai, M; Khanal, S; Sabbah, HN; Sharov, VG; Todor, A | 1 |
| Anastasiou-Nana, MI; Margari, ZJ; Tsagalou, EP; Vassilopoulos, D | 1 |
| Eisen, HJ | 1 |
| Inagaki, K; Koyanagi, T; Mochly-Rosen, D; Noguchi, K; Ootani, A; Robbins, RC | 1 |
| Chang, DM; Chen, CH; Ho, TY; Kuo, SY; Lai, JH; Lin, KM; Yang, DH | 1 |
| Billingham, ME; Herskowitz, A; Mason, JW; McManus, BM; Moon, TE; O'Connell, JB; Rose, NR | 1 |
| Braun, K; Dengler, TJ; Kübler, W; Sack, FU; Tiefenbacher, CP; Zimmermann, R | 1 |
| Burnett, JC; Clavell, AL | 1 |
| Cavero, PG; Chatterjee, K; DeMarco, T; Galli, F; Keith, F; Sudhir, K | 1 |
| Gössinger, H; Heinz, G; Kreiner, G; Laczkovics, A; Mösslacher, H; Siostrzonek, P; Stümpflen, A; Teufelsbauer, H | 1 |
| Casale, R; Elam, M; La Rovere, MT; Mortara, A; Tavazzi, L | 1 |
| Casaccia, M; di Summa, M; Marra, S; Mollo, F; Papandrea, C; Passarino, G; Pucci, A | 1 |
| Eisenhofer, G; Elam, M; Friberg, P; Rundqvist, B | 1 |
| Bergmann-Sverrisdottir, Y; Casale, R; Elam, M; Friberg, P; Mortara, A; Rundqvist, B | 1 |
| Barinaga, M | 1 |
| Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
| Andreassen, AK; Gullestad, L; Holm, T; Kvernebo, K; Simonsen, S | 1 |
| Veness, MJ | 1 |
| Asai, K; Hong, C; McKinsey, TA; Meguro, T; Olson, EN; Takagi, G; Vatner, SF | 1 |
| Chakfe, N; Charloux, A; Geny, B; Hardy, H; Lampert, E; Lonsdorfer, J; Mettauer, B; Piquard, F | 1 |
| Attramadal, H; Bjørnerheim, R; Clausen, OP; Oie, E | 1 |
| Barckhausen, P; Hasenfuss, G; Janssen, PM; Keweloh, B; Lehnart, SE; Maier, LS; Pieske, B; Prestle, J; Siegel, U; Zeitz, O | 1 |
| Hayashida, W; Kihara, Y; Sasayama, S; Yasaka, A | 1 |
| Bacigalupo, A; Endo, T; Fujimoto, K; Koike, T; Nakao, S; Nishio, M; Sakai, T; Sawada, K; Takashima, H | 1 |
| Bueno, OF; De Windt, LJ; Doevendans, PA; Molkentin, JD; van Rooij, E | 1 |
| Desjardins, V; Leung, TK; Pelletier, G; Waters, D | 1 |
| Bowler, JV; Peatfield, RC | 1 |
8 review(s) available for cyclosporine and Cardiac Failure
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.
Topics: Cell Survival; Cyclosporine; Drugs, Investigational; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Contraction; Myocytes, Cardiac; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Translational Research, Biomedical; Urea; Ventricular Remodeling | 2014 |
[Monitoring and adjustment of immunosuppression after heart transplantation].
Topics: Chronic Disease; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Graft Rejection; Graft Survival; Heart Failure; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Meta-Analysis as Topic; Monitoring, Immunologic; Mycophenolic Acid; Protein Kinases; Randomized Controlled Trials as Topic; Sirolimus; Survival Analysis; T-Lymphocytes; Tacrolimus; TOR Serine-Threonine Kinases; Treatment Outcome | 2009 |
Current trends in heart transplantation.
Topics: Cross-Cultural Comparison; Cyclosporine; Developing Countries; Europe; Forecasting; Health Services Needs and Demand; Heart Failure; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Survival Rate; Tissue and Organ Procurement | 2004 |
Cardiac transplantation in pediatric patients: fifteen-year experience of a single center.
Topics: Adolescent; Antiviral Agents; Bacterial Infections; Cardiomyopathy, Dilated; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Extracorporeal Membrane Oxygenation; Female; Follow-Up Studies; Ganciclovir; Germany; Graft Rejection; Heart Defects, Congenital; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Immunosuppressive Agents; Life Tables; Lymphoma, Non-Hodgkin; Male; Mycophenolic Acid; Pneumonia, Pneumocystis; Postoperative Complications; Reoperation; Retrospective Studies; Survival Analysis; Survival Rate; Tacrolimus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vascular Resistance; Virus Diseases | 2005 |
Immunosuppression on the horizon.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Calcineurin Inhibitors; Cyclosporine; Everolimus; Graft Survival; Heart Failure; Heart Transplantation; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Janus Kinase 3; Kidney Failure, Chronic; Prognosis; Protein Kinases; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2007 |
Physiologic and pathophysiologic roles of endothelin in the kidney.
Topics: Acute Kidney Injury; Animals; Body Water; Cyclosporine; Endothelins; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Homeostasis; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Radiation Injuries; Receptors, Endothelin; Renal Circulation; Sodium | 1994 |
Calcineurin and hypertrophic heart disease: novel insights and remaining questions.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Heart Failure; Humans; Signal Transduction; Tacrolimus | 2002 |
9 trial(s) available for cyclosporine and Cardiac Failure
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Clinical effects of cyclosporine in acute anterior myocardial infarction complicated by heart failure: A subgroup analysis of the CIRCUS Trial.
Topics: Anterior Wall Myocardial Infarction; Cardiotonic Agents; Cyclosporine; Disease Progression; Double-Blind Method; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies | 2019 |
Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation?
Topics: Adult; Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prognosis; Risk Factors; Survival Rate; Tacrolimus; Valganciclovir | 2014 |
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Everolimus; Female; Glomerular Filtration Rate; Graft Rejection; Heart Failure; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; TOR Serine-Threonine Kinases; Ventricular Function, Left | 2014 |
Myocyte growth, repair, and oxidative stress following pediatric heart transplantation.
Topics: Adolescent; Biomarkers; Biopsy; Cell Proliferation; Child; Child, Preschool; Cyclosporine; Female; Heart Failure; Heart Transplantation; Humans; Infant; Inflammation; Male; Muscle Cells; Oxidative Stress; Oxygen; Postoperative Period; Prospective Studies; Signal Transduction; Tacrolimus; Treatment Outcome | 2014 |
Cyclosporine before PCI in Patients with Acute Myocardial Infarction.
Topics: Aged; Combined Modality Therapy; Cyclophilins; Cyclosporine; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Female; Heart Failure; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Remodeling | 2015 |
The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction.
Topics: Aged; Anterior Wall Myocardial Infarction; Arrhythmias, Cardiac; Chi-Square Distribution; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heart Failure; Humans; Injections, Intravenous; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Myocardium; Pilot Projects; Stroke Volume; Thrombolytic Therapy; Time Factors; Treatment Outcome; Ventricular Function, Left | 2013 |
Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Biomarkers; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Postoperative Complications; Preoperative Care; Recombinant Fusion Proteins; Renal Insufficiency; Statistics as Topic; Stroke Volume; Time Factors; Treatment Outcome | 2005 |
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.
Topics: Adult; Autoantibodies; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Heart Failure; Humans; Immunoglobulin G; Immunosuppression Therapy; Male; Multivariate Analysis; Myocarditis; Myocardium; Prednisone; Stroke Volume; Survival Analysis; Treatment Outcome | 1995 |
49 other study(ies) available for cyclosporine and Cardiac Failure
| Article | Year |
|---|---|
Identifying Treatments for Stage C2 Heart Failure.
Topics: Cyclosporine; Heart Failure; Humans | 2022 |
Importance of endomyocardial biopsy in patients with myocarditis: A case report.
Topics: Adult; Biopsy; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Heart Failure; Humans; Male; Myocarditis; Prednisone; Video Recording | 2019 |
Perinatal ciclosporin A exposure elicits sex-related cardiac dysfunction and inflammation in the rat progeny.
Topics: Adiponectin; Animals; Animals, Newborn; Catalase; Cyclosporine; Dinoprost; Electrocardiography; Female; Heart Failure; Heart Ventricles; Hemodynamics; Inflammation; Male; Oxidative Stress; Perinatal Care; Rats; Rats, Wistar; Sex Factors; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2017 |
Oxidative and other stresses following pediatric heart transplantation.
Topics: Cyclosporine; Female; Heart Failure; Heart Transplantation; Humans; Male; Muscle Cells; Oxidative Stress; Tacrolimus | 2014 |
Treatment of feline asthma with ciclosporin in a cat with diabetes mellitus and congestive heart failure.
Topics: Animals; Asthma; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Heart Failure; Immunosuppressive Agents; Treatment Outcome | 2015 |
Long term biventricular support with Berlin Heart Excor in a Septuagenarian with giant-cell myocarditis.
Topics: Aged; Anti-Bacterial Agents; Cyclosporine; Extracorporeal Membrane Oxygenation; Follow-Up Studies; Heart Failure; Heart-Assist Devices; Humans; Immunosuppressive Agents; Male; Myocarditis; Prednisolone; Prosthesis-Related Infections; Pseudomonas Infections; Shock, Cardiogenic; Staphylococcal Infections; Treatment Outcome | 2015 |
[Role of calcineurin in down-regulation of left ventricular transmural voltage- dependent K(+) currents in mice with heart failure].
Topics: Action Potentials; Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Down-Regulation; Heart; Heart Failure; Mice; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Ventricular Function, Left | 2015 |
CardioPulse: Cyclosporine to reduce myocardial infarction injury?
Topics: Chemokine CX3CL1; Cyclosporine; Heart Failure; Humans; Immunosuppressive Agents; Lymphocytes; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention | 2016 |
Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation: a case report.
Topics: Anemia, Aplastic; Child; Cyclophosphamide; Cyclosporine; Echocardiography; Extracorporeal Membrane Oxygenation; Female; Femoral Artery; Heart Failure; Hematopoietic Stem Cell Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Jugular Veins; Myocarditis; Respiratory Insufficiency | 2016 |
Mitochondrial OPA1, apoptosis, and heart failure.
Topics: Animals; Apoptosis; Cell Line; Cyclosporine; Cytochromes c; GTP Phosphohydrolases; Heart Failure; Humans; Membrane Proteins; Membrane Transport Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Proteins; Myocardial Ischemia; Rats; RNA, Messenger | 2009 |
Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Topics: Animals; Calcineurin; Cardiomegaly; Carrier Proteins; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phosphotransferases (Alcohol Group Acceptor); Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Receptors, Adrenergic, alpha-2; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2009 |
Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.
Topics: Animals; Calcineurin; Cardiomegaly; Carrier Proteins; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phosphotransferases (Alcohol Group Acceptor); Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Receptors, Adrenergic, alpha-2; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2009 |
Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.
Topics: Adolescent; Antilymphocyte Serum; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Sirolimus; Tacrolimus; Young Adult | 2010 |
Heart transplantation with ABO-identical versus ABO-compatible cardiac grafts: influence on long-term survival.
Topics: ABO Blood-Group System; Adult; Cyclosporine; Female; Glucocorticoids; Graft Survival; Heart Failure; Heart Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Models, Statistical; Prospective Studies; Risk Assessment; Sweden | 2010 |
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
Topics: Animals; Apoptosis; Cell Proliferation; Cyclophilins; Cyclosporine; Heart Failure; Heart Ventricles; Lactones; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Peptidyl-Prolyl Isomerase F; Spiro Compounds; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Analysis of spontaneous adverse drug reaction (ADR) reports using supplementary information.
Topics: Adverse Drug Reaction Reporting Systems; Biostatistics; Creatinine; Cyclosporine; Databases, Factual; Diuretics; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Immunosuppressive Agents; Kidney Transplantation; Likelihood Functions; Models, Statistical; Netherlands; Odds Ratio; United States; United States Food and Drug Administration | 2011 |
CaMKII determines mitochondrial stress responses in heart.
Topics: Animals; Apoptosis; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclosporine; Female; Heart; Heart Failure; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardium; Reperfusion Injury; Serine; Stress, Physiological | 2012 |
Cyclosporin A does not block exercise-induced cardiac hypertrophy.
Topics: Analysis of Variance; Animals; Blotting, Western; Cyclosporine; Disease Models, Animal; Electron Transport Complex IV; Heart Failure; Heart Function Tests; Hypertrophy, Left Ventricular; Male; Physical Conditioning, Animal; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Treatment Outcome | 2002 |
[Aortic valve replacement in a renal transplant recipient].
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; Cyclosporine; Heart Failure; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Time Factors; Transplantation, Homologous | 2003 |
[The heart transplant in Lausanne from 1987 to 2003].
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Failure; Heart Transplantation; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Survival Rate; Switzerland | 2003 |
Ca2+-dependent modulation of single human cardiac L-type calcium channels by the calcineurin inhibitor cyclosporine.
Topics: Barium; Calcineurin Inhibitors; Calcium; Calcium Channels, L-Type; Cell Line; Cyclosporine; Heart; Heart Atria; Heart Failure; Humans; Membrane Potentials; Muscle Cells; Recombinant Proteins; Ventricular Function | 2004 |
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy.
Topics: Analysis of Variance; Biopsy; Cardiomyopathy, Dilated; Child, Preschool; Cyclosporine; Endocardium; Female; Follow-Up Studies; Heart Failure; Humans; Immunosuppressive Agents; Infant; Male; Myocarditis; Prednisone; Ventricular Dysfunction, Left | 2004 |
Incidence of serum creatine kinase elevation and its relation to medications used after heart transplantation.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Child; Creatine Kinase; Cyclosporine; Diabetes Complications; Female; Heart Failure; Heart Transplantation; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Care; Postoperative Complications; Prednisolone | 2005 |
Development of ulcerative colitis after heart transplantation during immunosuppressive therapy.
Topics: Biopsy; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Disease Progression; Heart Failure; Heart Transplantation; Humans; Ileostomy; Immunosuppressive Agents; Intestinal Mucosa; Long-Term Care; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Complications; Predictive Value of Tests; Prednisolone; Recurrence; Reoperation | 2005 |
Long-term results of pediatric heart transplantation.
Topics: Adult; Cardiomyopathy, Dilated; Child; Child, Preschool; Cyclosporine; Female; Heart Failure; Heart Transplantation; Humans; Immunosuppression Therapy; Infant; Male; Postoperative Complications; Retrospective Studies; Survival Rate | 2005 |
Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes.
Topics: Adenosine Triphosphate; Animals; Cell Respiration; Chronic Disease; Cyclosporine; Disease Models, Animal; Dogs; Electron Transport Complex IV; Enzyme Inhibitors; Heart Failure; Heart Ventricles; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Myocytes, Cardiac; Ventricular Dysfunction, Left | 2005 |
Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.
Topics: Animals; Cell Respiration; Cyclosporine; Disease Models, Animal; Dogs; Heart Failure; In Vitro Techniques; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Sarcolemma | 2007 |
Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.
Topics: Brain Diseases; Cardiomyopathy, Dilated; Cyclosporine; Everolimus; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Sirolimus; Ventricular Dysfunction, Right | 2007 |
Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model.
Topics: Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Heart Failure; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocarditis; Neutrophil Infiltration; Peptide Fragments; Protein Kinase C-epsilon; Protein Kinase Inhibitors; T-Lymphocytes; Transplantation, Heterotopic | 2007 |
Etanercept as a rescue agent in patient with adult onset Still's disease complicated with congestive heart failure.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Ferritins; Glucocorticoids; Heart Failure; Humans; Immunoglobulin G; Immunosuppressive Agents; Myocarditis; Radiography, Thoracic; Receptors, Tumor Necrosis Factor; Recovery of Function; Still's Disease, Adult-Onset; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult | 2008 |
Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantation.
Topics: Adult; Aged; Cyclosporine; Endothelins; Female; Heart Failure; Heart Transplantation; Humans; Kidney Diseases; Male; Middle Aged | 1995 |
Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: influence of cyclosporine therapy.
Topics: Analysis of Variance; Blood Vessels; Cardiomyopathy, Dilated; Combined Modality Therapy; Cyclosporine; Female; Forearm; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Myocardial Ischemia; Plethysmography; Time Factors | 1994 |
Relief of diastolic cardiac dysfunction after cyclosporine withdrawal in a cardiac transplant recipient.
Topics: Coronary Disease; Cyclosporine; Diastole; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Ventricular Function, Left | 1993 |
Is sympathetic neural hyperactivity in chronic heart failure affected by heart transplantation?
Topics: Cyclosporine; Heart Failure; Heart Transplantation; Humans; Immunosuppression Therapy; Middle Aged; Muscles; Pressoreceptors; Sympathetic Nervous System | 1993 |
Pathologic changes in a long-term heterotopic heart transplant survivor.
Topics: Coronary Disease; Cyclosporine; Fatal Outcome; Graft Occlusion, Vascular; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Proliferating Cell Nuclear Antigen; Transplantation, Heterotopic | 1995 |
Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation.
Topics: Adult; Case-Control Studies; Cyclosporine; Electrophysiology; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Metabolic Clearance Rate; Middle Aged; Muscle, Skeletal; Myocardium; Norepinephrine; Sympathetic Nervous System; Sympathomimetics; Tritium | 1996 |
Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation.
Topics: Cyclosporine; Electrocardiography; Heart Failure; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Longitudinal Studies; Middle Aged; Muscle, Skeletal; Sympathetic Fibers, Postganglionic | 1997 |
Signaling path may lead to better heart-failure therapies.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; GATA4 Transcription Factor; Heart Failure; Humans; Mice; Myocardium; NFATC Transcription Factors; Nuclear Proteins; Signal Transduction; Tacrolimus; Transcription Factors | 1998 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |
Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients.
Topics: Acetylcholine; Adult; Area Under Curve; Blood Pressure; Case-Control Studies; Cyclosporine; Endothelium, Vascular; Female; Fingers; Forearm; Heart Failure; Heart Transplantation; Humans; Hyperemia; Immunosuppressive Agents; Iontophoresis; Laser-Doppler Flowmetry; Male; Microcirculation; Nitroprusside; Regional Blood Flow; Skin; Vasodilation; Vasodilator Agents; Vasomotor System | 1998 |
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Glucocorticoids; Head and Neck Neoplasms; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Opportunistic Infections; Prednisolone; Skin Neoplasms | 1998 |
Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure.
Topics: Animals; Aorta; Aorta, Abdominal; Aorta, Thoracic; Cyclosporine; Disease Susceptibility; Enzyme Inhibitors; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Ligation; Male; Mice | 1999 |
Lack of acute cyclosporine nephrotoxicity in late heart-transplant recipients.
Topics: Acute Disease; Atrial Natriuretic Factor; Biomarkers; Creatinine; Cyclosporine; Glomerular Filtration Rate; Graft Rejection; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Prognosis | 2000 |
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats.
Topics: Animals; Apoptosis; Cardiomegaly; Cyclosporine; Echocardiography; Fibrosis; Gene Expression; Heart; Heart Failure; Male; Myocardial Infarction; Myocardium; Pressure; Rats; Rats, Wistar; Renin; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium.
Topics: Animals; Calcium; Cold Temperature; Cyclosporine; Depression, Chemical; Dose-Response Relationship, Drug; Heart Failure; Humans; Immunosuppressive Agents; In Vitro Techniques; Myocardial Contraction; Myocardium; Oxygen Consumption; Rabbits; Sarcoplasmic Reticulum | 2000 |
Cardiac calcineurin during transition from hypertrophy to heart failure in rats.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Body Weight; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Down-Regulation; Electrocardiography; Heart Failure; Hemodynamics; Hypertension; Hypertrophy; Myocardium; Rats; Rats, Inbred Dahl; Thiazepines | 2000 |
Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure.
Topics: Adult; Anabolic Agents; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Diabetes Complications; Female; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Iron Overload; Methylprednisolone; T-Lymphocytes; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |
Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis.
Topics: Autoimmune Diseases; Azathioprine; Biopsy; Cardiomyopathy, Dilated; Cyclosporine; Drug Therapy, Combination; Electrocardiography; Female; Giant Cells; Heart Failure; Hemodynamics; Humans; Immunity, Cellular; Immunoenzyme Techniques; Immunosuppressive Agents; Middle Aged; Myocarditis; Myocardium; Prednisone | 1992 |
Delusions and cyclosporine toxicity.
Topics: Cyclosporine; Delusions; Dose-Response Relationship, Drug; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Postoperative Complications | 1992 |